Journal of Dermatologic Research And Therapy

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Dermatologic Research And Therapy-Pharmacology of Chinese medicines exhibiting anticancer-Zhi-Ling YU

China

Associate Director,
Technology Development Division,
School of Chinese Medicine,
Hong Kong Baptist University.

Send an Email

Zhi-Ling YU

Address:

School of Chinese Medicine,
Hong Kong Baptist University,
Kowoon Tong, Hong Kong, China.

Research Interests:

Pharmacology of Chinese medicines exhibiting anticancer, anti-inflammation and anti-fatty liver properties, improving learning and memory, and affecting melanogenesis. Pathophysiology of cancer and nonalcoholic fatty liver disease.

Biography:

  • Zhi-Ling Yu obtained a Bachelor degree of Pharmacy in Chinese Medicine from Henan College of Chinese Medicine, Zhengzhou, China and a PhD degree in Biochemistry from Hong University of Science and Technology, Hong Kong. 
  • Currently He is studying anticancer, antiinflammation and antifatty liver Chinese herbs using molecular biology approaches in Hong Kong Baptist University as an associate professor.
  • Dr. Zhi-Ling YU is presently working as a Professor in the school of Chinese medicine, at Hong Kong Baptist University, China. 
  • Until 2014 he worked as a CEO at Institute for the Advancement of Chinese Medicine (IACM) Ltd, in the Hong Kong Baptist University, China. 
  • He received his Ph.D. in Biochemistry, Hong Kong University of Science and Technology, china. 
  • He had number of research outputs in the field of Nanoscience. 
  • And he is also a responsible member in professional societies and Organizing Committees.
  • Pharmacology of Chinese medicines exhibiting anticancer, anti-inflammation and anti-fatty liver properties, improving learning and memory, and affecting melanogenesis.
  • Pathophysiology of cancer and nonalcoholic fatty liver disease.